IL22 and Alzheimer disease: The downregulation of FLG is confirmed to be systemic and secondary to dysregulated expression of Th2-associated (IL-4, IL-13) and Th22-associated (IL-22) cytokines observed in the skin of AD patients [9,11,41,42,66,69].